PLATINUM

Nitto Denko Avecia Inc.

With over 20 years of experience in oligonucleotide development and production, and over 1000 sequences manufactured, Nitto Denko Avecia Inc. is a leader in the advancing oligo therapeutic market. Our mission is to continue to build value for our customers as they progress through drug development into commercialization.

PLATINUM

Purolite® Life Sciences

Purolite Life Sciences brings Purolite’s innovative thinking and distinguished history of resin technology expertise to the global Life Sciences marketplace. Over three decades, Purolite has grown into the world’s premier resin technology manufacturer and innovation leader, with production plants and advanced research labs across the globe.
Purolite Life Sciences provides API’s, enzyme carriers and immobilized enzymes, and resins for purification and separation to support research and development, and production-scale applications in pharmaceuticals, protein purification, food production, bioprocessing, fine chemical and additional markets. With a team of world-class researchers and scientists, we develop novel, high-demand and customized products to meet customer needs.

GOLD

Bachem

Bachem is specialized in the process development and manufacturing of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe, the US and Asia, the group has a global reach and towards its customers, Bachem shows total commitment to quality, innovation and partnership.
Bachem. Pioneering Partner for Peptides

GOLD

CSBio

CSBio is a leading peptide and instrumentation manufacturing company based in Silicon Valley in Menlo Park, California.
For over 25 years, CSBio has been providing high quality custom peptides, cGMP peptides, and automated peptide synthesizers to the global biotech community. Our peptide products and instrumentation can be found in production laboratories and pharmaceutical companies worldwide.
We have state of the art cGMP manufacturing facilities to take you from tox studies through market commercialization, and we’ve recently launched a proven line of oligonucleotide synthesizers for small scale R&D to large scale manufacturing.

GOLD

Iris Biotech

Iris Biotech specializes in reagents for Drug Discovery, Drug Delivery, and Diagnostics. We have know-how and production capabilities to manufacture and supply products for following areas:
1. Starting Materials for Peptide Synthesis, Peptidomimetics and Medicinal Chemistry.
2. Technologies for Drug Delivery.Worldwide largest portofolio of PEGylation reagents, selection of certain Poly(amino acids). Different ADC linkers.
3. Reagents for Life Sciences and Diagnostics.§
We are carrying out Contract Manufacturing projects in these areas. Our strong points are unusual derivatives with one or several chiral centers.

GOLD

Zeochem

Swiss Quality Products – Chemistry. Pure. Efficient The Swiss company Zeochem AG is a world leader in manufacturing of (modified) silica gel for the purification of any kind of molecule, but especially for charged molecules like Peptides, Insulins and Oligonucleotides. Although we produce excellent traditional stationary phases, our primary focus is offering innovating solutions like our successful mixed-mode ZEOsphere DRP. ZEOsphere DRP is an answer to the need for faster, better and therefore a cheaper purification, all the while displaying higher efficiency (purity, yield and throughput) through controllable, reproducible and reinforcing multiple interactions. The efficiency, consistent and reliability of our ZEOsphere product lines relies on narrow particle and pore size distribution, excellent mechanical/chemical stability and high specific surface area. Zeochem AG is a company of CPH Chemie + Paper Holding AG, listed on the Six Swiss Exchange.

SILVER

CEM Corporation

CEM Corporation is the leader in peptide synthesis, specializing in microwave synthesis instrumentation, novel methodology development, and online reagents. We pioneered the use of microwave energy for peptide synthesis, initially creating the first commercially available system and demonstrating its application. Since that time, CEM has steadily raised the bar with new, high throughput SPPS solutions for library synthesis and scale up to 1 kg peptide quantities for production laboratories. Stop by our booth to learn more.

SILVER

ChemGenes

ChemGenes, an ISO 9001 certified company established in 1981, is the industry leader in manufacturing oligonucleotide synthesis reagents and has consistently provided the highest quality phosphoramidites and solid supports in the market. Our facility, just outside of Boston/Cambridge Massachusetts USA, is setup for bulk manufacturing of therapeutic grade phosphoramidite and solid support DNA/RNA synthesis products for GMP grade oligonucleotide manufacturing. Additionally, ChemGenes carries the widest variety of modified phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic Acid research. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.

SILVER

Kinovate Life Sciences

Kinovate Life Sciences is a leading provider of solid supports for the oligonucleotide therapeutic industry. KLS’s proprietary solid supports Nittophase® and Nittophase®HL, with conventional and custom loadings of up to 400mmol/g, have proven superior performance in synthesis scales from mmol to hundreds of mmols, increasing synthesis yields and improving impurity profiles. NittoPhase® and NittoPhase® HL loaded solid supports are manufactured under cGMP guideline.

ASSOCIATE PARTNER

Rethage Advisors LLC

Pharmaceutical Contract Development & Manufacturing Advisory for Sponsors and CDMO’s
20+ years CDMO expertise for the benefit of our clients.
Deals: numerous commercial supply agreements and other deals structured & negotiated; developed short and long term solutions for small to very large volumes and complexity.
Growth: organic and in-organic; including 12 acquisitions, divestitures and JV’s.
Value: increased top and bottom line, multiple turn abounds of CDMO’s.
Organizations: built leadership teams and transformed cultures.
Global: extensive expertise to work with US, EU and Asian companies.

IN COLLABORATION WITH

KwaZulu-Natal University

The University of KwaZulu-Natal was formed on 1 January 2004 as a result of the merger between the University of Durban-Westville and the University of Natal. The new university brings together the rich histories of both the former Universities.
The two KwaZulu-Natal universities were among the first batch of South African institutions to merge in 2004 in accordance with the government’s higher educational restructuring plans that will eventually see the number of higher educational institutions in South Africa reduced from 36 to 21. Confirmed by a Cabinet decision in December 2002, the mergers are the culmination of a wide-ranging consultative process on the restructuring of the Higher Education Sector that began in the early 1990s.